TY - JOUR AU - Licari, A. AU - Ciprandi, G. AU - Marseglia, A. AU - Castagnoli, R. AU - Barberi, S. AU - Caimmi, S. AU - Marseglia, G. L. PY - 2014 DA - 2014// TI - Current recommendations and emerging options for the treatment of allergic rhinitis JO - Exp Rev Clin Immunol VL - 10 UR - https://doi.org/10.1586/1744666X.2014.955476 DO - 10.1586/1744666X.2014.955476 ID - Licari2014 ER - TY - JOUR AU - Brozek, J. L. AU - Bousquet, J. AU - Baena-Cagnani, C. E. AU - Bonini, S. AU - Canonica, G. W. AU - Casale, T. B. AU - Wijk, R. G. AU - Ohta, K. AU - Zuberbier, T. AU - Schunemann, H. J. PY - 2010 DA - 2010// TI - Allergic rhinitis and its impact on asthma (aria) guidelines: 2010 revision JO - J Allergy Clin Immunol VL - 126 UR - https://doi.org/10.1016/j.jaci.2010.06.047 DO - 10.1016/j.jaci.2010.06.047 ID - Brozek2010 ER - TY - JOUR AU - Scadding, G. K. AU - Williams, A. PY - 2008 DA - 2008// TI - The burden of allergic rhinitis as reported by uk patients compared with their doctors JO - Rhinology VL - 46 ID - Scadding2008 ER - TY - JOUR AU - Laforest, L. AU - Bousquet, J. AU - Pietri, G. AU - Sazonov Kocevar, V. AU - Yin, D. AU - Pacheco, Y. AU - Ganse, E. PY - 2005 DA - 2005// TI - Quality of life during pollen season in patients with seasonal allergic rhinitis with or without asthma JO - Int Arch Allergy Immunol VL - 136 UR - https://doi.org/10.1159/000083955 DO - 10.1159/000083955 ID - Laforest2005 ER - TY - JOUR AU - Bousquet, J. AU - Khaltaev, N. AU - Cruz, A. A. AU - Denburg, J. AU - Fokkens, W. J. AU - Togias, A. AU - Zuberbier, T. AU - Baena-Cagnani, C. E. AU - Canonica, G. W. AU - Weel, C. PY - 2008 DA - 2008// TI - Allergic rhinitis and its impact on asthma (aria) 2008 update (in collaboration with the world health organization, ga(2)len and allergen) JO - Allergy VL - 63 UR - https://doi.org/10.1111/j.1398-9995.2007.01620.x DO - 10.1111/j.1398-9995.2007.01620.x ID - Bousquet2008 ER - TY - JOUR AU - Scadding, G. K. PY - 2008 DA - 2008// TI - Hay fever and asthma: are we failing our patients? JO - Drugs Today VL - 44 ID - Scadding2008 ER - TY - JOUR AU - Keith, P. K. AU - Desrosiers, M. AU - Laister, T. AU - Schellenberg, R. R. AU - Waserman, S. PY - 2012 DA - 2012// TI - The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients JO - Allergy Asthma Clin Immunol VL - 8 UR - https://doi.org/10.1186/1710-1492-8-7 DO - 10.1186/1710-1492-8-7 ID - Keith2012 ER - TY - JOUR AU - Marple, B. F. AU - Fornadley, J. A. AU - Patel, A. A. AU - Fineman, S. M. AU - Fromer, L. AU - Krouse, J. H. AU - Lanier, B. Q. AU - Penna, P. PY - 2007 DA - 2007// TI - Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction JO - JAMA Otolaryngol Head Neck Surg VL - 136 UR - https://doi.org/10.1016/j.otohns.2007.02.031 DO - 10.1016/j.otohns.2007.02.031 ID - Marple2007 ER - TY - JOUR AU - Benninger, M. AU - Farrar, J. R. AU - Blaiss, M. AU - Chipps, B. AU - Ferguson, B. AU - Krouse, J. AU - Marple, B. AU - Storms, W. AU - Kaliner, M. PY - 2010 DA - 2010// TI - Evaluating approved medications to treat allergic rhinitis in the united states: an evidence-based review of efficacy for nasal symptoms by class JO - Ann Allergy Asthma Immunol VL - 104 UR - https://doi.org/10.1016/j.anai.2009.11.020 DO - 10.1016/j.anai.2009.11.020 ID - Benninger2010 ER - TY - JOUR AU - Scadding, G. K. AU - Durham, S. R. AU - Mirakian, R. AU - Jones, N. S. AU - Leech, S. C. AU - Farooque, S. AU - Ryan, D. AU - Walker, S. M. AU - Clark, A. T. AU - Dixon, T. A. PY - 2008 DA - 2008// TI - BSACI guidelines for the management of allergic and non-allergic rhinitis JO - Clin Exp Allergy VL - 38 UR - https://doi.org/10.1111/j.1365-2222.2007.02888.x DO - 10.1111/j.1365-2222.2007.02888.x ID - Scadding2008 ER - TY - JOUR AU - Wallace, D. V. AU - Dykewicz, M. S. AU - Bernstein, D. I. AU - Blessing-Moore, J. AU - Cox, L. AU - Khan, D. A. AU - Lang, D. M. AU - Nicklas, R. A. AU - Oppenheimer, J. AU - Portnoy, J. M. PY - 2008 DA - 2008// TI - The diagnosis and management of rhinitis: an updated practice parameter JO - J Allergy Clin Immunol VL - 122 UR - https://doi.org/10.1016/j.jaci.2008.06.003 DO - 10.1016/j.jaci.2008.06.003 ID - Wallace2008 ER - TY - JOUR AU - Blaiss, M. S. PY - 2007 DA - 2007// TI - Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis JO - Allergy Asthma Proc VL - 28 UR - https://doi.org/10.2500/aap.2007.28.2948 DO - 10.2500/aap.2007.28.2948 ID - Blaiss2007 ER - TY - JOUR AU - Weiner, J. M. AU - Abramson, M. J. AU - Puy, R. M. PY - 1998 DA - 1998// TI - Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials JO - BMJ VL - 317 UR - https://doi.org/10.1136/bmj.317.7173.1624 DO - 10.1136/bmj.317.7173.1624 ID - Weiner1998 ER - TY - JOUR AU - Castillo, J. AU - Dimov, V. PY - 2014 DA - 2014// TI - Investigational drugs for the treatment of allergic rhinitis JO - Expert Opin Invest Drugs VL - 23 UR - https://doi.org/10.1517/13543784.2014.907271 DO - 10.1517/13543784.2014.907271 ID - Castillo2014 ER - TY - JOUR AU - Mandhane, S. N. AU - Shah, J. H. AU - Thennati, R. PY - 2011 DA - 2011// TI - Allergic rhinitis: an update on disease, present treatments and future prospects JO - Int Immunopharmacol VL - 11 UR - https://doi.org/10.1016/j.intimp.2011.07.005 DO - 10.1016/j.intimp.2011.07.005 ID - Mandhane2011 ER - TY - JOUR AU - Kostenis, E. AU - Ulven, T. PY - 2006 DA - 2006// TI - Emerging roles of DP and CRTH2 in allergic inflammation JO - Trends Mol Med VL - 12 UR - https://doi.org/10.1016/j.molmed.2006.02.005 DO - 10.1016/j.molmed.2006.02.005 ID - Kostenis2006 ER - TY - JOUR AU - Pettipher, R. AU - Hansel, T. T. AU - Armer, R. PY - 2007 DA - 2007// TI - Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases JO - Nature Rev Drug Discov VL - 6 UR - https://doi.org/10.1038/nrd2266 DO - 10.1038/nrd2266 ID - Pettipher2007 ER - TY - JOUR AU - Xue, L. AU - Salimi, M. AU - Panse, I. AU - Mjosberg, J. M. AU - McKenzie, A. N. AU - Spits, H. AU - Klenerman, P. AU - Ogg, G. PY - 2014 DA - 2014// TI - Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells JO - J Allergy Clin Immunol VL - 133 UR - https://doi.org/10.1016/j.jaci.2013.10.056 DO - 10.1016/j.jaci.2013.10.056 ID - Xue2014 ER - TY - JOUR AU - Pettipher, R. PY - 2008 DA - 2008// TI - The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses JO - Br J Pharmacol VL - 153 ID - Pettipher2008 ER - TY - JOUR AU - Xue, L. AU - Barrow, A. AU - Pettipher, R. PY - 2009 DA - 2009// TI - Interaction between prostaglandin D and chemoattractant receptor-homologous molecule expressed on TH2 cells mediates cytokine production by TH2 lymphocytes in response to activated mast cells JO - Clin Exp Immunol VL - 156 UR - https://doi.org/10.1111/j.1365-2249.2008.03871.x DO - 10.1111/j.1365-2249.2008.03871.x ID - Xue2009 ER - TY - JOUR AU - Iwasaki, M. AU - Nagata, K. AU - Takano, S. AU - Takahashi, K. AU - Ishii, N. AU - Ikezawa, Z. PY - 2002 DA - 2002// TI - Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis JO - J Invest Dermatol VL - 119 UR - https://doi.org/10.1046/j.1523-1747.2002.01862.x DO - 10.1046/j.1523-1747.2002.01862.x ID - Iwasaki2002 ER - TY - JOUR AU - Gyles, S. L. AU - Xue, L. AU - Townsend, E. R. AU - Wettey, F. AU - Pettipher, R. PY - 2006 DA - 2006// TI - A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (TH2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ TH2 lymphocytes in response to mast cell supernatants JO - Immunology VL - 119 UR - https://doi.org/10.1111/j.1365-2567.2006.02440.x DO - 10.1111/j.1365-2567.2006.02440.x ID - Gyles2006 ER - TY - JOUR AU - Pettipher, R. AU - Hansel, T. T. PY - 2008 DA - 2008// TI - Antagonists of the prostaglandin D2 receptor CRTH2 JO - Drug News Perspect VL - 21 UR - https://doi.org/10.1358/dnp.2008.21.6.1246831 DO - 10.1358/dnp.2008.21.6.1246831 ID - Pettipher2008 ER - TY - JOUR AU - Liu, H. AU - Zheng, M. AU - Qiao, J. AU - Dang, Y. AU - Zhang, P. AU - Jin, X. PY - 2014 DA - 2014// TI - Role of prostaglandin D2/CRTH2 pathway on asthma exacerbation induced by Aspergillus fumigatus JO - Immunology VL - 142 UR - https://doi.org/10.1111/imm.12234 DO - 10.1111/imm.12234 ID - Liu2014 ER - TY - JOUR AU - Hall, I. P. AU - Fowler, A. V. AU - Gupta, A. AU - Tetzlaff, K. AU - Nivens, M. C. AU - Sarno, M. AU - Finnigan, H. A. AU - Bateman, E. D. AU - Rand, S. u. t. h. e. r. l. a. n. d. E. PY - 2015 DA - 2015// TI - Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment JO - Pulm Pharmacol Ther VL - 32 UR - https://doi.org/10.1016/j.pupt.2015.03.003 DO - 10.1016/j.pupt.2015.03.003 ID - Hall2015 ER - TY - JOUR AU - Uller, L. AU - Mathiesen, J. M. AU - Alenmyr, L. AU - Korsgren, M. AU - Ulven, T. AU - Hogberg, T. AU - Andersson, G. AU - Persson, C. G. AU - Kostenis, E. PY - 2007 DA - 2007// TI - Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation JO - Resp Res VL - 8 UR - https://doi.org/10.1186/1465-9921-8-16 DO - 10.1186/1465-9921-8-16 ID - Uller2007 ER - TY - JOUR AU - Strasser, D. S. AU - Farine, H. AU - Holdener, M. AU - Zisowsky, J. AU - Roscher, R. AU - Hoerner, J. AU - Gehin, M. AU - Sidharta, P. N. AU - Dingemanse, J. AU - Groenen, P. PY - 2015 DA - 2015// TI - Development of a decision-making biomarker for CRTH2 antagonism in clinical studies JO - N Horiz Transl Med VL - 2 ID - Strasser2015 ER - TY - JOUR AU - Krug, N. AU - Gupta, A. AU - Badorrek, P. AU - Koenen, R. AU - Mueller, M. AU - Pivovarova, A. AU - Hilbert, J. AU - Wetzel, K. AU - Hohlfeld, J. M. AU - Wood, C. PY - 2014 DA - 2014// TI - Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis JO - J Allergy Clin Immunol VL - 133 UR - https://doi.org/10.1016/j.jaci.2013.10.013 DO - 10.1016/j.jaci.2013.10.013 ID - Krug2014 ER - TY - JOUR AU - Horak, F. AU - Zieglmayer, P. AU - Zieglmayer, R. AU - Lemell, P. AU - Collins, L. P. AU - Hunter, M. G. AU - Steiner, J. AU - Lewis, T. AU - Payton, M. A. AU - Perkins, C. M. PY - 2012 DA - 2012// TI - The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial JO - Allergy VL - 67 ID - Horak2012 ER - TY - JOUR AU - Gonem, S. AU - Berair, R. AU - Singapuri, A. AU - Hartley, R. AU - Laurencin, M. AU - Bacher, G. AU - Lu, C. AU - Holzhauer, B. AU - Bourne, M. AU - Mistry, V. PY - 2014 DA - 2014// TI - Phase 2a randomized placebo-controlled trial of the oral prostaglandin D2 receptor (DP2/ CRTH2) antagonist QAW039 in eosinophilic asthma JO - Eur Respir J VL - 44 UR - https://doi.org/10.1183/09031936.00001814 DO - 10.1183/09031936.00001814 ID - Gonem2014 ER - TY - JOUR AU - Erpenbeck, V. J. AU - Salapatek, A. M. AU - Patel, P. AU - Sanni, J. AU - Dubois, G. AU - Zhou, P. AU - Perry, S. AU - Larbig, M. PY - 2014 DA - 2014// TI - Efficacy and safety of 10 day treatment with the CRTH2 antagonist QAV680 evaluated in patients with allergic rhinitis in an environmental exposure chamber JO - Eur Resp J VL - 44 ID - Erpenbeck2014 ER - TY - JOUR AU - Sandham, D. A. AU - Arnold, N. AU - Aschauer, H. AU - Bala, K. AU - Barker, L. AU - Brown, L. AU - Brown, Z. AU - Budd, D. AU - Cox, B. AU - Docx, C. PY - 2013 DA - 2013// TI - Discovery and characterization of NVP-QAV680, a potent and selective CRTH2 receptor antagonist suitable for clinical testing in allergic diseases JO - Bioorg Med Chem VL - 21 UR - https://doi.org/10.1016/j.bmc.2013.08.025 DO - 10.1016/j.bmc.2013.08.025 ID - Sandham2013 ER - TY - JOUR AU - Fretz, H. AU - Valdenaire, A. AU - Pothier, J. AU - Hilpert, K. AU - Gnerre, C. AU - Peter, O. AU - Leroy, X. AU - Riederer, M. A. PY - 2013 DA - 2013// TI - Identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1 h-pyrido[4,3-b]indol-5(2 h)-yl)acetic acid (setipiprant/ACT-129968), a potent, selective, and orally bioavailable chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) antagonist JO - J Med Chem VL - 56 UR - https://doi.org/10.1021/jm400122f DO - 10.1021/jm400122f ID - Fretz2013 ER - TY - JOUR AU - Sidharta, P. N. AU - Diamant, Z. AU - Dingemanse, J. PY - 2014 DA - 2014// TI - Single- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects JO - Fundam Clin Pharmacol VL - 28 UR - https://doi.org/10.1111/fcp.12079 DO - 10.1111/fcp.12079 ID - Sidharta2014 ER - TY - JOUR AU - Hoch, M. AU - Wank, J. AU - Kluge, I. AU - Wagner-Redeker, W. AU - Dingemanse, J. PY - 2013 DA - 2013// TI - Disposition and metabolism of setipiprant, a selective oral CRTH2 antagonist, in humans JO - Drugs RD VL - 13 UR - https://doi.org/10.1007/s40268-013-0031-7 DO - 10.1007/s40268-013-0031-7 ID - Hoch2013 ER - TY - JOUR AU - Baldoni, D. AU - Mackie, A. AU - Gutierrez, M. AU - Theodor, R. AU - Dingemanse, J. PY - 2013 DA - 2013// TI - Setipiprant, a selective oral antagonist of human CRTH2: relative bioavailability of a capsule and a tablet formulation in healthy female and male subjects JO - Clin Ther VL - 35 UR - https://doi.org/10.1016/j.clinthera.2013.09.003 DO - 10.1016/j.clinthera.2013.09.003 ID - Baldoni2013 ER - TY - JOUR AU - Diamant, Z. AU - Sidharta, P. N. AU - Singh, D. AU - O’Connor, B. J. AU - Zuiker, R. AU - Leaker, B. R. AU - Silkey, M. AU - Dingemanse, J. PY - 2014 DA - 2014// TI - Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics JO - Clin Exp Allergy VL - 44 UR - https://doi.org/10.1111/cea.12357 DO - 10.1111/cea.12357 ID - Diamant2014 ER - TY - JOUR AU - Santanello, N. C. AU - DeMuro-Mercon, C. AU - Shah, S. R. AU - Schenkel, E. J. AU - Ratner, P. H. AU - Dass, S. B. AU - Norquist, J. M. AU - Philip, G. PY - 2006 DA - 2006// TI - Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis JO - Allergy Asthma Proc VL - 27 UR - https://doi.org/10.2500/aap.2006.27.2849 DO - 10.2500/aap.2006.27.2849 ID - Santanello2006 ER - TY - JOUR AU - Juniper, E. F. AU - Thompson, A. K. AU - Ferrie, P. J. AU - Roberts, J. N. PY - 1999 DA - 1999// TI - Validation of the standardized version of the rhinoconjunctivitis quality of life questionnaire JO - J Allergy Clin Immunol VL - 104 UR - https://doi.org/10.1016/S0091-6749(99)70380-5 DO - 10.1016/S0091-6749(99)70380-5 ID - Juniper1999 ER - TY - JOUR AU - Bretz, F. AU - Pinheiro, J. C. AU - Branson, M. PY - 2005 DA - 2005// TI - Combining multiple comparisons and modeling techniques in dose-response studies JO - Biometrics VL - 61 UR - https://doi.org/10.1111/j.1541-0420.2005.00344.x DO - 10.1111/j.1541-0420.2005.00344.x ID - Bretz2005 ER - TY - JOUR AU - Bornkamp, B. AU - Pinheiro, J. C. AU - Bretz, F. PY - 2009 DA - 2009// TI - MCPMOD—an R package for the design and analysis of dose-finding studies JO - J Stat Soft VL - 29 UR - https://doi.org/10.18637/jss.v029.i07 DO - 10.18637/jss.v029.i07 ID - Bornkamp2009 ER - TY - JOUR AU - Krause, A. AU - Zisowsky, J. AU - Strasser, D. S. AU - Gehin, M. AU - Sidharta, P. N. AU - Groenen, P. M. A. AU - Dingemanse, J. PY - 2016 DA - 2016// TI - Pharmacokinetic/pharmacodynamic modelling of receptor internalization with CRTH2 antagonists to optimize dose selection JO - Clin Pharmacokinet VL - 55 UR - https://doi.org/10.1007/s40262-015-0354-3 DO - 10.1007/s40262-015-0354-3 ID - Krause2016 ER - TY - JOUR AU - Gehin, M. AU - Strasser, D. S. AU - Zisowsky, J. AU - Farine, H. AU - Groenen, P. M. AU - Dingemanse, J. AU - Sidharta, P. N. PY - 2015 DA - 2015// TI - A novel CRTH2 antagonist: single- and multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ACT-453859 in healthy subjects JO - J Clin Pharmacol VL - 55 UR - https://doi.org/10.1002/jcph.478 DO - 10.1002/jcph.478 ID - Gehin2015 ER - TY - JOUR AU - Erpenbeck, V. J. AU - Salapatek, A. M. AU - Patel, P. AU - Carew, D. AU - Dubois, G. AU - Perry, S. AU - Larbig, M. PY - 2014 DA - 2014// TI - QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber JO - Eur Resp J VL - 44 ID - Erpenbeck2014 ER - TY - STD TI - European Medicines Association (EMEA). Guideline on the development of medicinal products for the treatment of allergic rhinoconjunctivitis. 2004. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003554.pdf. Accessed 7 Oct 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003554.pdf ID - ref45 ER - TY - JOUR AU - Curran, M. P. AU - Scott, L. J. AU - Perry, C. M. PY - 2004 DA - 2004// TI - Cetirizine: a review of its use in allergic disorders JO - Drugs VL - 64 UR - https://doi.org/10.2165/00003495-200464050-00008 DO - 10.2165/00003495-200464050-00008 ID - Curran2004 ER -